ACE and Aortic dissection: In this population-based cohort study of 6978 adults with aortic dissection, the risk of all-cause mortality was lower among patients prescribed an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB) and those prescribed a β-blocker than among those prescribed other antihypertension agents.